1、 LEE J,ROH J L.Epithelial-mesenchymal plasticity:Implications for ferroptosis vulnerability and cancer therapy[J].Crit Rev Oncol Hematol,2023(185):103964. LEE J,ROH J L.Epithelial-mesenchymal plasticity:Implications for ferroptosis vulnerability and cancer therapy[J].Crit Rev Oncol Hematol,2023(185):103964.
2、 DOS SANTOS A F,FAZELI G,XAVIER DA SILVA T N,et al.Ferroptosis:Mechanisms and implications for cancer development and therapy response[J].Trends Cell Biol,2023,33(12):1062-1076. DOS SANTOS A F,FAZELI G,XAVIER DA SILVA T N,et al.Ferroptosis:Mechanisms and implications for cancer development and therapy response[J].Trends Cell Biol,2023,33(12):1062-1076.
3、 FOUSEK K,HORN L A,PALENA C.Interleukin-8:A chemokine at the intersection of cancer plasticity,angiogenesis,and immune suppression[J].Pharmacol Ther,2021(219):107692. FOUSEK K,HORN L A,PALENA C.Interleukin-8:A chemokine at the intersection of cancer plasticity,angiogenesis,and immune suppression[J].Pharmacol Ther,2021(219):107692.
4、 KIM H J,CANTOR H,COSMOPOULOS K.Overcoming immune checkpoint blockade resistance via EZH2 inhibition[J].Trends Immunol,2020,41(10):948-963. KIM H J,CANTOR H,COSMOPOULOS K.Overcoming immune checkpoint blockade resistance via EZH2 inhibition[J].Trends Immunol,2020,41(10):948-963.
5、 EICH M L,ATHAR M,FERGUSON J E,et al.EZH2-targeted therapies in cancer:Hype or a reality[J].Cancer Res,2020,80(24):5449-5458. EICH M L,ATHAR M,FERGUSON J E,et al.EZH2-targeted therapies in cancer:Hype or a reality[J].Cancer Res,2020,80(24):5449-5458.
6、 KANG N,ECCLESTON M,CLERMONT P L,et al.EZH2 inhibition:A promising strategy to prevent cancer immune editing[J].Epigenomics,2020,12(16):1457-1476. KANG N,ECCLESTON M,CLERMONT P L,et al.EZH2 inhibition:A promising strategy to prevent cancer immune editing[J].Epigenomics,2020,12(16):1457-1476.
7、 SINGH S,GOURI V,SAMANT M.TGF-β in correlation with tumor progression,immunosuppression and targeted therapy in colorectal cancer[J].Med Oncol,2023,40(11):335. SINGH S,GOURI V,SAMANT M.TGF-β in correlation with tumor progression,immunosuppression and targeted therapy in colorectal cancer[J].Med Oncol,2023,40(11):335.
8、 KATSUNO Y,DERYNCK R.Epithelial plasticity,epithelial-mesenchymal transition,and the TGF-β family[J].Dev Cell,2021,56(6):726-746. KATSUNO Y,DERYNCK R.Epithelial plasticity,epithelial-mesenchymal transition,and the TGF-β family[J].Dev Cell,2021,56(6):726-746.
9、 WATABE T,TAKAHASHI K,PIETRAS K,et al.Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system[J].Semin Cancer Biol,2023(92):130-138. WATABE T,TAKAHASHI K,PIETRAS K,et al.Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system[J].Semin Cancer Biol,2023(92):130-138.
10、 WANG X,EICHHORN P J A,THIERY J P.TGF-β,EMT,and resistance to anti-cancer treatment[J].Semin Cancer Biol,2023(97):1-11. WANG X,EICHHORN P J A,THIERY J P.TGF-β,EMT,and resistance to anti-cancer treatment[J].Semin Cancer Biol,2023(97):1-11.
11、 李桂霞,毕宇鑫,郝瑞家,等.靶向紧密连接蛋白6的药物在癌症治疗中的研究进展[J].生物工程学报,2023,39(4):1304-1313. 李桂霞,毕宇鑫,郝瑞家,等.靶向紧密连接蛋白6的药物在癌症治疗中的研究进展[J].生物工程学报,2023,39(4):1304-1313.
12、 SHI Z D,PANG K,WU Z X,et al.Tumor cell plasticity in targeted therapy-induced resistance:Mechanisms and new strategies[J].Signal Transduct Target Ther,2023,8(1):113. SHI Z D,PANG K,WU Z X,et al.Tumor cell plasticity in targeted therapy-induced resistance:Mechanisms and new strategies[J].Signal Transduct Target Ther,2023,8(1):113.
13、 WINDER M,VIRóS A.Mechanisms of drug resistance in melanoma[J].Handb Exp Pharmacol,2018(249):91-108. WINDER M,VIRóS A.Mechanisms of drug resistance in melanoma[J].Handb Exp Pharmacol,2018(249):91-108.
14、 SINGH N,RAMNARINE V R,SONG J H,et al.The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer[J].Nat Commun,2021,12(1):7349. SINGH N,RAMNARINE V R,SONG J H,et al.The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer[J].Nat Commun,2021,12(1):7349.
15、 KU S Y,ROSARIO S,WANG Y,et al.Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity,metastasis,and antiandrogen resistance[J].Science,2017,355(6320):78-83. KU S Y,ROSARIO S,WANG Y,et al.Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity,metastasis,and antiandrogen resistance[J].Science,2017,355(6320):78-83.
16、 MU P,ZHANG Z,BENELLI M,et al.SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer[J].Science,2017,355(6320):84-88. MU P,ZHANG Z,BENELLI M,et al.SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer[J].Science,2017,355(6320):84-88.
17、 CASTILHO R M,SQUARIZE C H,ALMEIDA L O.Epigenetic modifications and head and neck cancer:Implications for tumor progression and resistance to therapy[J].Int J Mol Sci,2017,18(7):1506. CASTILHO R M,SQUARIZE C H,ALMEIDA L O.Epigenetic modifications and head and neck cancer:Implications for tumor progression and resistance to therapy[J].Int J Mol Sci,2017,18(7):1506.
18、 WANG T,CHUFFART F,BOUROVA-FLIN E,et al.Histone variants:Critical determinants in tumour heterogeneity[J].Front Med,2019,13(3):289-297. WANG T,CHUFFART F,BOUROVA-FLIN E,et al.Histone variants:Critical determinants in tumour heterogeneity[J].Front Med,2019,13(3):289-297.
19、 LI L,ZENG Q,BHUTKAR A,et al.GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth[J].Cancer Cell,2018,33(4):736-751.e5. LI L,ZENG Q,BHUTKAR A,et al.GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth[J].Cancer Cell,2018,33(4):736-751.e5.
20、 LAMBERT A W,WEINBERG R A.Linking EMT programmes to normal and neoplastic epithelial stem cells[J].Nat Rev Cancer,2021,21(5):325-338. LAMBERT A W,WEINBERG R A.Linking EMT programmes to normal and neoplastic epithelial stem cells[J].Nat Rev Cancer,2021,21(5):325-338.
21、 GUPTA P B,PASTUSHENKO I,et al.SKIBINSKI A.Phenotypic plasticity:Driver of cancer initiation,progression,and therapy resistance[J].Cell Stem Cell,2019,24(1):65-78. GUPTA P B,PASTUSHENKO I,et al.SKIBINSKI A.Phenotypic plasticity:Driver of cancer initiation,progression,and therapy resistance[J].Cell Stem Cell,2019,24(1):65-78.
22、 GAMEIRO P A,STRUHL K.Nutrient deprivation elicits a transcriptional and translational inflammatory response coupled to decreased protein synthesis[J].Cell Rep,2018,24(6):1415-1424. GAMEIRO P A,STRUHL K.Nutrient deprivation elicits a transcriptional and translational inflammatory response coupled to decreased protein synthesis[J].Cell Rep,2018,24(6):1415-1424.
23、 HANAHAN D.Hallmarks of cancer:New dimensions[J].Cancer Discov,2022,12(1):31-46. HANAHAN D.Hallmarks of cancer:New dimensions[J].Cancer Discov,2022,12(1):31-46.
24、 LI Y,LV Z,ZHANG S,et al.Genetic fate mapping of transient cell fate reveals N-cadherin activity and function in tumor metastasis[J].Dev Cell,2020,54(5):593-607.e5. LI Y,LV Z,ZHANG S,et al.Genetic fate mapping of transient cell fate reveals N-cadherin activity and function in tumor metastasis[J].Dev Cell,2020,54(5):593-607.e5.
25、 JOLLY M K,MANI S A,LEVINE H.Hybrid epithelial/mesenchymal phenotype(s):The “fittest” for metastasis?[J].Biochim Biophys Acta Rev Cancer,2018,1870(2):151-157. JOLLY M K,MANI S A,LEVINE H.Hybrid epithelial/mesenchymal phenotype(s):The “fittest” for metastasis?[J].Biochim Biophys Acta Rev Cancer,2018,1870(2):151-157.
26、 DESHMUKH A P,VASAIKAR S V,TOMCZAK K,et al.Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing[J].Proc Natl Acad Sci U S A,2021,118(19):e2102050118. DESHMUKH A P,VASAIKAR S V,TOMCZAK K,et al.Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing[J].Proc Natl Acad Sci U S A,2021,118(19):e2102050118.
27、 ESPOSITO M,MONDAL N,GRECO T M,et al.Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis[J].Nat Cell Biol,2019,21(5):627-639. ESPOSITO M,MONDAL N,GRECO T M,et al.Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis[J].Nat Cell Biol,2019,21(5):627-639.
28、 KR?GER C,AFEYAN A,MRAZ J,et al.Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells[J].Proc Natl Acad Sci USA,2019,116(15):7353-7362. KR?GER C,AFEYAN A,MRAZ J,et al.Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells[J].Proc Natl Acad Sci USA,2019,116(15):7353-7362.
29、 BAKIR B,CHIARELLA A M,PITARRESI J R,et al.EMT,MET,plasticity,and tumor metastasis[J].Trends Cell Biol,2020,30(10):764-776. BAKIR B,CHIARELLA A M,PITARRESI J R,et al.EMT,MET,plasticity,and tumor metastasis[J].Trends Cell Biol,2020,30(10):764-776.
30、 FEDELE M,SGARRA R,BATTISTA S,et al.The epithelial-Mesenchymal transition at the crossroads between metabolism and tumor progression[J].Int J Mol Sci,2022,23(2):800. FEDELE M,SGARRA R,BATTISTA S,et al.The epithelial-Mesenchymal transition at the crossroads between metabolism and tumor progression[J].Int J Mol Sci,2022,23(2):800.
31、 LAFAVE L M,KARTHA V K,MA S,et al.Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma[J].Cancer Cell,2020,38(2):212-228.e13. LAFAVE L M,KARTHA V K,MA S,et al.Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma[J].Cancer Cell,2020,38(2):212-228.e13.
32、 GROVES S M,IRELAND A,LIU Q,et al.Cancer hallmarks define a continuum of plastic cell states between small cell lung cancer archetypes[M/OL].bioRxiv,2021:2021.01.22.427865[2024-01-04].https://www.biorxiv.org/content/10.1101/2021.01.22.427865v1. GROVES S M,IRELAND A,LIU Q,et al.Cancer hallmarks define a continuum of plastic cell states between small cell lung cancer archetypes[M/OL].bioRxiv,2021:2021.01.22.427865[2024-01-04].https://www.biorxiv.org/content/10.1101/2021.01.22.427865v1.
33、 BIEHS B,DIJKGRAAF G J P,PISKOL R,et al.A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition[J].Nature,2018,562(7727):429-433. BIEHS B,DIJKGRAAF G J P,PISKOL R,et al.A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition[J].Nature,2018,562(7727):429-433.
34、 KRAH N M,NARAYANAN S M,YUGAWA D E.et al.PreventionYUGAWA D E.Prevention and reversion of pancreatic tumorigenesis through a differentiation-based mechanism[J].Dev Cell,2019,50(6):744-754.e4. KRAH N M,NARAYANAN S M,YUGAWA D E.et al.PreventionYUGAWA D E.Prevention and reversion of pancreatic tumorigenesis through a differentiation-based mechanism[J].Dev Cell,2019,50(6):744-754.e4.
35、 ZHAO C,GOMEZ G A,ZHAO Y,et al.ETV2 mediates endothelial transdifferentiation of glioblastoma[J].Signal Transduct Target Ther,2018(3):4. ZHAO C,GOMEZ G A,ZHAO Y,et al.ETV2 mediates endothelial transdifferentiation of glioblastoma[J].Signal Transduct Target Ther,2018(3):4.
36、 WANG S,QU Y,XIA P,et al.Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer[J].Cell Res,2020,30(7):610-622. WANG S,QU Y,XIA P,et al.Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer[J].Cell Res,2020,30(7):610-622.
37、 DOU C,LIU Z,TU K,et al.P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts[J].Gastroenterology,2018,154(8):2209-2221.e14. DOU C,LIU Z,TU K,et al.P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts[J].Gastroenterology,2018,154(8):2209-2221.e14.
38、 KONG F E,LI G M,TANG Y Q,et al.Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate[J].Sci Transl Med,2021,13(579):eabb6282. KONG F E,LI G M,TANG Y Q,et al.Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate[J].Sci Transl Med,2021,13(579):eabb6282.
39、 MARJANOVIC N D,HOFREE M,CHAN J E,et al.Emergence of a high-plasticity cell state during lung cancer evolution[J].Cancer Cell,2020,38(2):229-246.e13. MARJANOVIC N D,HOFREE M,CHAN J E,et al.Emergence of a high-plasticity cell state during lung cancer evolution[J].Cancer Cell,2020,38(2):229-246.e13.
40、 ISHAY-RONEN D,DIEPENBRUCK M,KALATHUR R K R,et al.Gain fat-lose metastasis:Converting invasive breast cancer cells into adipocytes inhibits cancer metastasis[J].Cancer Cell,2019,35(1):17-32.e6. ISHAY-RONEN D,DIEPENBRUCK M,KALATHUR R K R,et al.Gain fat-lose metastasis:Converting invasive breast cancer cells into adipocytes inhibits cancer metastasis[J].Cancer Cell,2019,35(1):17-32.e6.
41、 IMAMURA J,GANGULY S,MUSKARA A,et al.Lineage plasticity and treatment resistance in prostate cancer:the intersection of genetics,epigenetics,and evolution[J].Front Endocrinol,2023(14):1191311. IMAMURA J,GANGULY S,MUSKARA A,et al.Lineage plasticity and treatment resistance in prostate cancer:the intersection of genetics,epigenetics,and evolution[J].Front Endocrinol,2023(14):1191311.
42、 HAN H,WANG Y,CURTO J,et al.Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis[J].Cell Rep,2022,39(1):110595. HAN H,WANG Y,CURTO J,et al.Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis[J].Cell Rep,2022,39(1):110595.
43、 LE MAGNEN C,SHEN M M,ABATE-SHEN C.Lineage plasticity in cancer progression and treatment[J].Annu Rev Cancer Biol,2018(2):271-289. LE MAGNEN C,SHEN M M,ABATE-SHEN C.Lineage plasticity in cancer progression and treatment[J].Annu Rev Cancer Biol,2018(2):271-289.
44、 ZHANG Y,PAN Y,XIE C,et al.MiR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis[J].Cell Death Dis,2018,9(7):777. ZHANG Y,PAN Y,XIE C,et al.MiR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis[J].Cell Death Dis,2018,9(7):777.
45、 PEREKATT A O,SHAH P P,CHEUNG S,et al.SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium[J].Cancer Res,2018,78(17):4878-4890. PEREKATT A O,SHAH P P,CHEUNG S,et al.SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium[J].Cancer Res,2018,78(17):4878-4890.
46、 HU Y B,YAN C,MU L,et al.Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance[J].Oncogene,2019,38(11):1951-1965. HU Y B,YAN C,MU L,et al.Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance[J].Oncogene,2019,38(11):1951-1965.
47、 FANG S,LIU M,LI L,et al.Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway[J].Oncogene,2019,38(21):4061-4074. FANG S,LIU M,LI L,et al.Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway[J].Oncogene,2019,38(21):4061-4074.
48、 Erin N,Grahovac J,Brozovic A,et al.Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance[J].Drug Resist Updat,2020(53):100715. Erin N,Grahovac J,Brozovic A,et al.Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance[J].Drug Resist Updat,2020(53):100715.
49、 QIN S,JIANG J,LU Y,et al.Emerging role of tumor cell plasticity in modifying therapeutic response[J].Signal Transduct Target Ther,2020,5(1):228. QIN S,JIANG J,LU Y,et al.Emerging role of tumor cell plasticity in modifying therapeutic response[J].Signal Transduct Target Ther,2020,5(1):228.
50、 PéREZ-GONZáLEZ A,BéVANT K,BLANPAIN C.Cancer cell plasticity during tumor progression,metastasis and response to therapy[J].Nat Cancer,2023,4(8):1063-1082. PéREZ-GONZáLEZ A,BéVANT K,BLANPAIN C.Cancer cell plasticity during tumor progression,metastasis and response to therapy[J].Nat Cancer,2023,4(8):1063-1082.
51、 BOUMAHDI S,de SAUVAGE F J.The great escape:tumour cell plasticity in resistance to targeted therapy[J].Nat Rev Drug Discov,2020,19(1):39-56. BOUMAHDI S,de SAUVAGE F J.The great escape:tumour cell plasticity in resistance to targeted therapy[J].Nat Rev Drug Discov,2020,19(1):39-56.
52、 DENTRO S C,LESHCHINER I,HAASE K,et al.Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes[J].Cell,2021,184(8):2239-2254.e39. DENTRO S C,LESHCHINER I,HAASE K,et al.Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes[J].Cell,2021,184(8):2239-2254.e39.
